about
PD-1/PD-L1 Blockade Therapy for Tumors with Downregulated MHC Class I Expression.The Escape of Cancer from T Cell-Mediated Immune Surveillance: HLA Class I Loss and Tumor Tissue Architecture.Neoantigen Targeting-Dawn of a New Era in Cancer Immunotherapy?The Broad Spectrum of Human Natural Killer Cell Diversity.Immunomodulation by ionizing radiation-impact for design of radio-immunotherapies and for treatment of inflammatory diseases.HLA class I loss and PD-L1 expression in lung cancer: impact on T-cell infiltration and immune escape.Immune Curbing of Cancer Stem Cells by CTLs Directed to NANOG.
P2860
Q33839204-BA6FD1C5-FD0E-4944-8E90-6722E507C99EQ39164068-FFB8EDBA-B8CA-484F-8683-9D32514A6AF5Q47221163-09282DD8-E20B-4445-BBF4-246826BC95F9Q47373461-FC50F7E2-BB91-44F1-B91B-BC89C8C75EF6Q48193685-98564166-46B8-481B-8EBC-883A0743E976Q49296790-31D4AC32-47E2-415B-BFB5-B4CB4A5EE47DQ55424304-E0E0CF4D-1B8E-4451-8002-2E63F19B69F4
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Rejection versus escape: the tumor MHC dilemma.
@en
Rejection versus escape: the tumor MHC dilemma.
@nl
type
label
Rejection versus escape: the tumor MHC dilemma.
@en
Rejection versus escape: the tumor MHC dilemma.
@nl
prefLabel
Rejection versus escape: the tumor MHC dilemma.
@en
Rejection versus escape: the tumor MHC dilemma.
@nl
P2093
P2860
P1476
Rejection versus escape: the tumor MHC dilemma.
@en
P2093
Federico Garrido
Francisco Ruiz-Cabello
Natalia Aptsiauri
P2860
P2888
P304
P356
10.1007/S00262-016-1947-X
P577
2016-12-31T00:00:00Z